Li & Fung Ltd.

  • ID: 1771352
  • Standard & Poors
1 of 3

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Large scale and operational flexibility Cash generative, asset-light operations Strong financial flexibility and good liquidity A weaker outlook for sales growth and profitability Large exposure to the U.S. consumer market Increased leverage because of a strong acquisition appetite The rating on Hong Kong-based consumer goods trading and sourcing operator Li & Fung Ltd. reflects the company's large scale and operational flexibility; its cash-generative, asset-light operations; its strong financial flexibility; and good liquidity. These strengths are tempered by a weaker outlook for Li & Fung's sales growth and profitability, its large exposure to the U.S. consumer market, and its increased leverage as a result of a strong acquisition appetite. The company is 31.65%-owned by Li & Fung (1937) Ltd., a private...

Companies mentioned in this report are: Li & Fung Ltd.
Action: Review

Note: Product cover images may vary from those shown
2 of 3

Li & Fung Ltd.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.